Author

P. L. Campbell

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

D. A. Fox· 2 shared D. Khanna· 2 shared A. Sawalha· 1 shared B. R. Martin· 1 shared D. Kahl· 1 shared D. M. Rohraff· 1 shared E. M. Lisabeth· 1 shared E. N. Model· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

D. A. Fox

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Inhibition of histone readers bromodomain extra-terminal proteins alleviates skin fibrosis in experimental models of scleroderma

S. Vichaikul, M. Gurrea-Rubio, M. A. Amin, P. L. Campbell, Q. Wu, M. N. Mattichak, W. D. Brodie, P. J. Palisoc, M. Ali, S. Muraoka, J. H. Ruth, E. N. Model, D. M. Rohraff, J. L. Hervoso, Y. Mao-Draayer, , P.-S. Tsou

This study shows that inhibiting BET proteins, particularly BRD4, reduces skin fibrosis in scleroderma models by affecting calcium signaling and gene expression.

bioRxiv · Aug 7, 2020Pharmacology & Toxicology

Identification of Pirin as a Molecular Target of the CCG-1423/CCG-203971 Series of Anti-Fibrotic and Anti-Metastatic Compounds

E. M. Lisabeth, D. Kahl, I. Gopallawa, S. E. Haynes, S. A. Misek, P. L. Campbell, T. S. Dexheimer, D. Khanna, D. A. Fox, X. Jin, B. R. Martin, S. D. Larsen, R. R. Neubig

This study identifies pirin as the molecular target of the CCG-1423/CCG-203971 compounds, showing its role in modulating MRTF-dependent gene expression and fibrosis.

bioRxiv · Oct 31, 2018Pharmacology & Toxicology